Biochem Pharmacol 2001 Oct 1;62(7):933-42
Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat.
Stuart JD, Lee FW, Simpson Noel D, Kadwell SH, Overton LK, Hoffman CR, Kost TA, Tippin
TK, Yeager RL, Batchelor KW, Bramson HN.
Division of Biochemistry, Glaxo Wellcome Inc., 5 Moore Drive, Research Triangle Park, NC
27709, USA. jds14989@gsk.com
The interaction of baculovirus expressed rat steroid 5alpha-reductase types 1 and 2 (r5AR1
and r5AR2) with
17beta-N-(2,5-bis(trifluoromethyl)phenyl)carbamoyl-4-aza-5alpha-androst-1-en-3-one
(GI198745) was investigated at pH 7 and 37 degrees. This 5alpha-reductase inhibitor was
found previously to be a time-dependent inhibitor of the two human 5alpha-reductase
isozymes. In contrast, we demonstrate in the present study that although GI198745 is a
potent time-dependent inhibitor of r5AR2, it is a classical rapid-equilibrium inhibitor of
r5AR1. This type of behavior with human and rat 5alpha-reductases has been shown for the
inhibitor 17beta-(N-tert-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one (finasteride), a
current therapy for benign prostatic hyperplasia. Inhibition of r5AR1 by GI198745 was
competitive with testosterone and followed Michaelis-Menten kinetics with a K(i) value of
0.3 +/- 0.02 nM. Data for the inhibition of r5AR2 by GI198745 were consistent with a
two-step mechanism, where K(i) is the dissociation constant for an initial
enzyme-inhibitor complex and k(3) is the rate constant for the second slow step. The
pseudo-bimolecular rate constant (k(3)/K(i)) for the association of GI198745 with r5AR2
was (2.0 +/- 0.4) x 10(7) M(-1) sec(-1). The high affinity of this inhibitor for r5AR2 was
further demonstrated by the inability of the enzyme-inhibitor complex to dissociate after
approximately 7 days of dialysis at 4 degrees. Both GI198745 and finasteride appear to
inactivate r5AR2 by apparent irreversible modification, but are classical, reversible
inhibitors of r5AR1. Therefore, we hypothesize that because of its pharmacokinetic
parameters and increased potency against r5AR1, GI198745 is more effective than
finasteride in preventing the growth of the rat prostate.